MENU

Table of Contents

Smarter Diabetes Management with CellmaEHR

Diabetes Management

Help Others Discover – Click to Share!

Facebook
Twitter
LinkedIn

Table of Contents

As of 2025 Diabetes is one of the most serious chronic health problems in the UK – with over 5.8 million individuals are living with diabetes which is the highest number ever reported. Of those, approximately 1.3 million are living with undiagnosed type 2 diabetes and an additional 6.3 million are at high risk of developing diabetes due to borderline blood sugars. This means that there are over 12.1 million adults in the UK urgently in need of Diabetes Management or prediabetes monitoring. 

Against this backdrop, healthcare professionals must address a complex clinical picture, one that requires early detection, multidisciplinary coordination, ongoing monitoring, complication management, and patient education. And they need to do it efficiently, safely, and in accordance with Clinical Guidelines set by NHS England and recommendations made by NICE. 

Cellma, our smart end-to-end EHR platform, is designed to support the complete care pathway, and gives clinicians real-time data, collaborative workflows, and clinical interventions at every step of Diabetes Management.  

Aligned with NHS Guidelines: How Cellma Meets National Clinical Standards 

Cellma has been developed with the NHS RightCare Diabetes Pathway, NICE’s Nine Key Care Processes, and standards established from NHS England. It allows: 

  • Automated recording for the nine annual review metrics: HbA1c, BP, cholesterol, BMI, renal function, retinal screening, foot assessment, smoking status and urinary albumin. 
  • Integrated care coordination of all the MDT members treating diabetes: diabetologists, dieticians, nurses, podiatrists, pharmacists and psychologists. 
  • Structured education referrals: e.g. DESMOND for type 2 or DAFNE for type 1, documented and audited in patient records. 
  • Accuracy in prescribing and titration: With alerts for drug interactions, contraindications (especially renal or hepatic impairment) and with insulin doses automatically recorded. 
     

Cellma supports the pathway from screening and diagnosis to treatment intensification and discharge from hospital and is consistent with NHS pathways, allowing continuity of care between primary, community, and secondary services.  

Clinical Conditions in Diabetes Management – And How Cellma Supports Them 

Clinical Condition 

How Cellma Supports 

Type 1 and Type 2 Diabetes Mellitus 

– Diagnostic support with HbA1c, C-peptide, and autoantibody panels- Differentiation between Type 1, Type 2, MODY, and LADA using age, BMI, autoimmune markers, and disease progression 

Diabetic Neuropathy 

– Tracks symptoms of peripheral and autonomic neuropathy- Records neurological exams, foot sensation tests, and vibration perception with visual trend analysis 

Diabetic Retinopathy 

– Auto-generates retinal screening referrals- Allows image upload and result tracking- Sends alerts for missed or abnormal screenings 

Diabetic Nephropathy 

– Monitors urinary albumin, eGFR, and serum creatinine- Provides trend analysis and early nephrology referral prompts- Supports medication adjustment based on renal function 

Diabetic Foot Ulcers 

– Includes MDT risk stratification tools- Documents ulcers, ABPI results, vascular assessments, and debridement- Facilitates podiatry coordination for offloading and footwear 

Gestational Diabetes 

– Manages glucose tolerance testing- Offers trimester-specific monitoring templates- Integrates with antenatal and obstetric pathways 

Psychosocial Issues in Diabetes 

– Embeds mental health assessments within the EPR- Links psychological inputs with HbA1c variability and medication adherence- Tracks behavioural support and coping strategies 

With Cellma, clinicians are not just documenting—they are engaging in proactive, clinical decision support backed by integrated, real-time data. 

Key Features of Cellma for Diabetes Management 

Cellma combines great functionality with clinical depth to address Diabetes Management’ real-world issues: 

Electronic Patient Record (EPR)  

  • Diabetes-specific care pathways are embedded in every patient record to allow coordinated, connected care.  
  • Fully customisable templates are available for diabetes assessments, comorbidity logs, MDT records.   
  • Automated linkage of each episode to relevant labs, scans, education programs, clinician notes.  

Laboratory Integration

  • Seamless integration with third-party pathology systems. 
  • Instant results for HbA1c, lipid profile, renal function, and glucose tolerance tests. 
  • Clinical alerts for values outside NICE target ranges. 

E-Pharmacy & Medication Safety

  • Assists with achieving safe prescribing of metformin, SGLT2 inhibitors, GLP-1 agonists, and various forms of insulins.  
  • Provides titration tools for basal-bolus insulins.  
  • Identifies contraindications, renal dosing adjustments and possible interactions with statins or ACE inhibitors.  

Multidisciplinary Team Co-ordination 

  • Input from dietitian regarding carbohydrate counting.  
  • Record from the nursing team regarding training in injecting technique.  
  • Podiatry templates records to review and monitor the status of a Charcot foot and evolution of foot ulceration. 
  • Plans of care between primary, secondary and community groups can be done without a break in care.

BI Reporting & Analytics 

  • Dashboards which show monitoring of HbA1c control across populations. 
  • Missed reviews prompting alerts and recurring issues related to non-adherents.  
  • Regional audit compliance and observation of QOF support. 

Document Management

  • Upload of education programme certificates (DESMOND/DAFNE). 
  • Shared access to patient-held records and self-monitoring logs. 

Patient Portal

  • Self-monitoring uploads (glucose diaries, insulin doses). 
  • Appointment tracking for annual reviews and specialist appointments. 
  • Messaging for questions, reminders, and alerts.

     

With Cellma there will be improved closure of care gaps, earlier identification of complications, and tracking of patient journeys with clinical certainty and administrative ease. 


Reinforced Data Security, Privacy and Compliance
 

Security is a must in Diabetes Management – and given the lifelong nature of the condition and type and quantity of clinical data being held, should always be the priority. 
Cellma is: 

  • Fully GDPR compliant 
  • NHS Digital DSP Toolkit certified 
  • Cyber Essentials Plus certified  
  • Role based access controlled 
  • End-to-end encryption protocols for data at rest and in transit

Only registered clinicians have a right to access one or more specific modules, with an audited record of every access from the point of registration throughout the entire patient journey to ensure patient confidentiality and clinician accountability. 

Diabetes affects 1 in 11 adults in the UK, and for every patient diagnosed, healthcare systems must manage dozens of clinical steps, lab checks, and multidisciplinary inputs. Cellma makes this journey not only manageable but clinically optimised and future ready. 

From screening to complication management, Cellma is the gold standard for Diabetes Management, helping NHS Trusts deliver precision, safety, and coordinated care at every stage. 
Ready to see Cellma in action? 

FAQs

How does Cellma support the full diabetes care pathway from diagnosis to treatment?

Cellma supports a whole diabetes care pathway that fully supports NHS RightCare and NICE guidelines with; tools to secure early screenings, accurate diagnosis (including differentiating between types of diabetes), undertaking initial assessments, referring to structured education, seeking referrals to pre diabetes management, treatment medication, tracking and caring for complications and returning at least annually for a review/ assessment. Cellma supports every aspect of Diabetes Management using automated workflows & real-time clinical decision support. 
 

Can Cellma support monitoring and preventing diabetic complications?

Absolutely! Cellma allows you to monitor key indicators e.g., Hba1c, renal function, retinal health and monitoring foot risk status on a continuous basis, trigger alerts where abnormal trends and issues arise such as screening dates which are overdue and help to direct the patient towards an appropriate course of well-balanced intervention. Accordingly, thereby minimizing the number of patients who will go on to develop complications such as diabetic nephropathy, retinopathy, neuropathy and foot ulcers. 

Is Cellma appropriate for multidisciplinary diabetes teams across a range of care environments?

Definitely. Cellma facilitates multi-disciplinary working between diabetologists, nurses, dietitians, podiatrists, pharmacists, psychologists, and GPs, including shared access to the latest patient letters/records, care plans, lab results and educational outcomes as well as real-time integrated Diabetes Management in primary, community, and hospital settings.